Oracle jumps 14% after Q3 earnings beat, in-line Q4 guide; ACADIA Pharmaceuticals down 15% as Phase 3 Pimavanserin study in Schizophrenia does not meet primary endpoint Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER AFTER EARNINGS
DOWN AFTER EARNINGS
- Ocular Therapeutix (OCUL) down 8.5%
- Alpha Teknova (TKNO) down 4.6%
- Vail Resorts (MTN) down 4.2%
- Casey's General Stores (CASY) down 2.9%
- Asana (ASAN) down 2.5%
ALSO LOWER
- ACADIA Pharmaceuticals (ACAD) down 15.5% after phase 3 Pimavanserin study in negative symptoms of Schizophrenia did not meet its primary endpoint
Symbols:
HRTG ORCL LFMD OCUL TKNO MTN - $224.74 /
+0.805 (+0.36%)
CASY - $299.08 /
-2.925 (-0.97%)
ASAN ACAD Keywords: fly intel, wall street, afterhours, movers, top stories, stocks